Skip to content

Similasan Eyes

Similasan Eyes is the eye-care line of the Swiss-origin Similasan brand of homeopathic remedies, distributed in North America by Similasan Corporation.

Last updated September 11, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

Similasan is a brand of natural, homeopathic remedies providing temporary symptomatic relief from ailments of the eyes, ears, nose, head, and chest. The brand originated in Switzerland in 1980, when Swiss druggist Armin Spaeni and two friends founded Similasan AG in Jonen, Switzerland. Similasan Corporation, the North American headquarters located just south of Denver, Colorado, was founded in 1987 with the introduction of Dry Eye Relief eye drops (formerly Eye Drops #1). Similasan eye drops and other remedies are sold in more than 20,000 retail establishments in the U.S.

History

Similasan AG in Jonen, Switzerland was founded by Swiss druggist Armin Spaeni from a line of combination homeopathic remedies that he created for his retail store. After realizing the success that his remedies had in treating his patients' ailments, Spaeni, along with two friends, founded Similasan AG in Jonen, Switzerland in 1980 to enable them to manufacture larger quantities of remedies for their rapidly growing customer base. Similasan quickly became one of the best selling brands in Swiss drugstores. Similasan Corporation, the North American headquarters located just south of Denver, Colorado, was founded in 1987 with the introduction of Dry Eye Relief eye drops (formerly known as Eye Drops #1).

Products and positioning

Natural, homeopathic remedies formulated using traditional homeopathic guidelines and produced according to FDA Good Manufacturing Practices (GMP).

  • Dry Eye Relief eye drops (formerly Eye Drops #1)

    Introduced with the founding of Similasan Corporation in 1987; described as hugely popular in Switzerland.

Sources4 sources

Cite this profile: Cite the canonical profile. /brand-wiki/similasan-eyes · Editorial policy · How profiles are compiled